Mediwatch PLC Cancellation and Scheme Effective (6053Y)
January 27 2014 - 9:26AM
UK Regulatory
TIDMMDW
RNS Number : 6053Y
Mediwatch PLC
27 January 2014
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, IN OR INTO ANY RESTRICTED JURISDICTIONS OR ANY OTHER
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION
Mediwatch plc
Scheme of Arrangement becomes Effective and Cancellation of
admission of Mediwatch Shares to trading on AIM
27 January 2014
The Directors of Mediwatch are pleased to announce that the
scheme of arrangement under Part 26 of the Companies Act 2006 (the
"Scheme") to effect the recommended acquisition of Mediwatch by
Laborie Medical Technologies Europe Limited ("Laborie") has now
become effective in accordance with its terms following a hearing
held earlier today when the High Court of Justice in England and
Wales confirmed the reduction of capital in connection with the
Scheme. The Court Order relating to the cancellation of the
Deferred Shares has also been delivered to the Registrar of
Companies along with the Court Orders sanctioning the Scheme and
confirming the cancellation of the Scheme Shares.
Mediwatch is now a wholly owned subsidiary of Laborie and has
been re-registered as a private limited company.
The admission to trading of Mediwatch Shares on AIM will be
cancelled with effect from 7.00 a.m. (London time) tomorrow, 28
January 2014.
The consideration of 6 pence per Mediwatch Share to be paid to
Mediwatch Shareholders pursuant to the terms of the Scheme is
expected to be dispatched (in the case of certificated holders of
Mediwatch Shares) or settled in CREST (in the case of
uncertificated holders of Mediwatch Shares) no later than 10
February 2014.
Unless otherwise stated, capitalised terms used but not defined
in this announcement have the same meanings as those in the Scheme
Document published by Mediwatch on 29 November 2013.
Enquiries:
Mediwatch +44 (0) 1788 547
Mark Hughes, Chief Financial Officer 888
SP Angel Corporate Finance LLP
(Financial adviser, nominated adviser and
broker to Mediwatch)
David Facey
Katy Birkin
Liz Yong +44 (0) 20 3463 2260
Important Notice
This announcement is for information purposes only and does not
constitute an offer to sell or an invitation to sell, purchase,
subscribe for or issue any securities, or the solicitation of an
offer to subscribe for any securities or the solicitation of any
vote or approval in any jurisdiction pursuant to the Acquisition or
otherwise, nor shall there be any purchase, sale or exchange of
securities or such solicitation in any jurisdiction in which such
offer, solicitation, sale or exchange would be unlawful under the
laws of such jurisdiction. Any response to the Acquisition or vote
in respect of the Scheme should be made only on the basis of the
information contained in the Scheme Document.
The release, publication or distribution of this announcement in
jurisdictions other than the United Kingdom may be restricted by
law and therefore any persons who are subject to the laws of any
jurisdiction other than the United Kingdom should inform themselves
about, and observe, any applicable requirements. This announcement
has been prepared for the purpose of complying with English law and
the City Code and the information disclosed may not be the same as
that which would have been disclosed if this announcement had been
prepared in accordance with the laws of jurisdictions outside the
United Kingdom.
Copies of this announcement and any formal documentation
relating to the Acquisition are not being, and must not be,
directly or indirectly, mailed or otherwise forwarded, distributed
or sent in or into or from any Restricted Jurisdiction and persons
receiving such documents (including custodians, nominees and
trustees) must not mail or otherwise forward, distribute or send
them in or into or from any Restricted Jurisdiction.
SP Angel Corporate Finance LLP, which is authorised and
regulated by the Financial Conduct Authority in the United Kingdom,
is acting exclusively as financial adviser to Mediwatch and no one
else in connection with the matters described in this announcement,
and will not be responsible for anyone other than Mediwatch for
providing the protections afforded to clients of SP Angel Corporate
Finance LLP nor for providing advice in relation to the matters
referred to in this announcement. Neither SP Angel Corporate
Finance LLP nor any of its affiliates, partners or employees owes
or accepts any duty, liability or responsibility whatsoever
(whether direct or indirect, whether in contract, in tort, under
statute or otherwise) to any person who is not a client of SP Angel
Corporate Finance LLP in connection with this announcement, any
statement contained herein or otherwise.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBSGDBSDDBGSR
Mediwatch (LSE:MDW)
Historical Stock Chart
From Oct 2024 to Oct 2024
Mediwatch (LSE:MDW)
Historical Stock Chart
From Oct 2023 to Oct 2024